- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aurobindo Pharma merges Pharmacin BV with Agile Pharma BV

Hyderabad: Aurobindo Pharma Limited has announced the merger of its two wholly owned step-down subsidiaries - Pharmacin B.V. and Agile Pharma B.V. Both the companies are incorporated in the Netherlands.
Effective July 1, 2025, Pharmacin B.V. has been merged with its holding company, Agile Pharma B.V., to enhance the substantive character of Agile with business activity and also saving regulatory and compliance expenses.
For the financial year ending March 31, 2025, Pharmacin B.V. posted a turnover of Rs 197.9 million, while Agile Pharma B.V. reported a turnover of Rs 66.4 million.
Both companies are involved in the manufacturing and marketing of pharmaceutical products.
In June, Aurobindo incorporated a new wholly owned subsidiary in the United States through its arm Aurobindo Pharma USA Inc. The newly formed entity, CRESEDEMO PHARMA LLC, was incorporated on June 13, 2025, with the aim of expanding the company’s pharmaceutical products business in the US market.
Read also: Aurobindo Pharma arm incorporates new subsidiary in US
Earlier, in May, Curateq Biologics Private Limited, another wholly owned subsidiary of the Company, incorporated a new wholly owned subsidiary in the Netherlands by the name of CuraTeQ Biologics B.V.
Read also: Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751